Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.

Harshal DeshmukhEmma BarkerThineshkrishna AnbarasanDaniel LevinSamira BellMiles D WithamJacob George

Published in: Cardiovascular therapeutics (2018)

Calcium channel blockers are associated with significantly increased survival and lower cardiovascular mortality particularly in patients with moderate RAS disease.

Keyphrases

cardiovascular events
angiotensin converting enzyme
risk factors
free survival
type diabetes
angiotensin ii